Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 145,415 | 144,788 | 125,736 | 162,640 | 182,132 |
| Marketable Securities | 35,831 | 49,659 | 95,680 | 62,777 | 90,763 |
| Receivables | 80,519 | 70,651 | 82,157 | 80,083 | 60,357 |
| Inventories | 1,099 | 1,705 | 735 | 479 | N/A |
| TOTAL | $279,542 | $275,727 | $311,596 | $314,053 | $341,487 |
| Non-Current Assets | |||||
| PPE Net | 16,335 | 16,844 | 17,274 | 17,175 | 17,854 |
| Intangibles | 153,738 | 157,214 | 160,690 | 164,166 | 166,063 |
| Other Non-Current Assets | 168,603 | 121,310 | 116,114 | 129,692 | 179,675 |
| TOTAL | $338,676 | $295,368 | $294,078 | $311,033 | $363,592 |
| Total Assets | $618,218 | $571,095 | $605,674 | $625,086 | $705,079 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 24,861 | 11,958 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 23,786 | 11,609 | 15,958 | 17,514 | 21,190 |
| Accrued Expenses | 43,207 | 34,818 | 45,550 | 41,670 | 38,271 |
| Other current liabilities | 423 | 355 | 247 | 699 | 14,985 |
| TOTAL | $94,984 | $62,336 | $66,027 | $64,489 | $79,973 |
| Non-Current Liabilities | |||||
| Long Term Debt | 122,614 | 135,220 | 146,898 | 146,605 | 146,316 |
| Deferred Revenues | 242 | 237 | 195 | 195 | 430 |
| Other Non-Current Liabilities | 438,513 | 385,731 | 377,452 | 427,087 | 470,405 |
| TOTAL | $567,185 | $526,811 | $529,799 | $578,176 | $620,236 |
| Total Liabilities | $662,169 | $589,147 | $595,826 | $642,665 | $700,209 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 153,157 | 151,941 | 151,869 | 149,756 | 149,592 |
| Common Shares | 153 | 152 | 151 | 149 | 150 |
| Retained earnings | -1,401,284 | -1,351,904 | -1,308,760 | -1,320,845 | -1,288,548 |
| Other shareholders' equity | -44 | -91 | -79 | -6 | -24 |
| TOTAL | $-43,951 | $-18,052 | $9,848 | $-17,579 | $4,870 |
| Total Liabilities And Equity | $618,218 | $571,095 | $605,674 | $625,086 | $705,079 |